VENLO (dpa-AFX) - Qiagen N.V.(QGENF, QGEN) announced Tuesday that it has set 2016 ambitions, including moving beyond significant U.S. HPV pressure, above-market growth from rest of portfolio, and investing to accelerate growth drivers.
The company also projects targeted geographic expansion and value-creating acquisitions.
For 2016, the company targets more than 1,750 installed systems in molecular testing.
The company further said it is setting course toward 2020 to accelerate growth and further innovation.
At the annual General meeting, Ross Levine was appointed as new member of Supervisory Board. Manfred Karobath is proposed as Chairman of Supervisory Board.
Copyright RTT News/dpa-AFX